纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | ATPBD1C |
Uniprot No | Q9UHW5 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1-284aa |
氨基酸序列 | MPRYAQLVMGPAGSGKSTYCATMVQHCEALNRSVQVVNLDPAAEHFNYSVMADIRELIEVDDVMEDDSLRFGPNGGLVFCMEYFANNFDWLENCLGHVEDDYILFDCPGQIELYTHLPVMKQLVQQLEQWEFRVCGVFLVDSQFMVESFKFISGILAALSAMISLEIPQVNIMTKMDLLSKKAKKEIEKFLDPDMYSLLEDSTSDLRSKKFKKLTKAICGLIDDYSMVRFLPYDQSDEESMNIALQHIDFAIQYGEDLEFKEPKEREDESSSMFDEYFQECQDE |
分子量 | 59.1 kDa |
蛋白标签 | GST-tag at N-terminal |
缓冲液 | 冻干粉 |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是假设的参考文献示例,基于对可能名称的推测(如V-ATPase亚基C或ATP6V1C1)。请注意,实际文献需通过学术数据库验证,建议核对蛋白命名准确性:
1. **"Expression and Functional Analysis of Recombinant Human V-ATPase Subunit C in Yeast"**
- **作者**: Johnson et al.
- **摘要**: 本研究报道了人源V-ATPase C亚基在酵母中的重组表达及功能特性,证实其参与液泡酸化调控,为质子泵组装机制提供新见解。
2. **"Structural Characterization of ATP6V1C1 and Its Role in Osteoclast Differentiation"**
- **作者**: Wang et al.
- **摘要**: 通过X射线晶体学解析ATP6V1C1的结构,并利用重组蛋白实验证明其在破骨细胞分化中的关键作用,提示其作为骨代谢疾病治疗靶点的潜力。
3. **"High-Yield Purification of Recombinant ATPBD1C for Drug Screening Applications"**
- **作者**: Martinez et al.
- **摘要**: 开发了一种高效纯化重组ATPBD1C蛋白的方法,应用于高通量药物筛选,发现新型抑制剂可调节溶酶体pH并抑制癌细胞增殖。
4. **"ATP6V1C1 Knockdown Alters Cellular pH Homeostasis and Enhances Chemotherapy Sensitivity"**
- **作者**: Kim et al.
- **摘要**: 研究显示,重组表达的ATP6V1C1蛋白在维持肿瘤细胞pH稳态中至关重要,其下调可增强化疗药物疗效,为联合治疗提供依据。
**注意**:以上文献为假设示例,"ATPBD1C"名称可能存在拼写或符号错误,建议核实为**ATP6V1C1**(人V-ATPase C亚基的正式基因符号)。请通过PubMed或Google Scholar以准确名称检索文献。
**Background of Recombinant Human V(ATPBD1C) Protein**
The recombinant human V(ATPBD1C) protein, also referred to as vacuolar-type H+-ATPase (V-ATPase) subunit ATP6V1C1. is a critical component of the V-ATPase complex, a multisubunit proton pump responsible for acidifying intracellular organelles (e.g., lysosomes, endosomes) and regulating extracellular pH in specific tissues. This ATP-binding domain-containing protein localizes to the cytoplasmic V1 domain of V-ATPase, facilitating ATP hydrolysis to drive proton translocation.
ATP6V1C1 plays vital roles in cellular processes such as membrane trafficking, protein degradation, and bone resorption. Dysregulation of V-ATPase function is implicated in diseases including osteoporosis, renal tubular acidosis, and cancer metastasis, where tumor cells exploit extracellular acidification to promote invasion. Recombinant ATP6V1C1 is typically produced in bacterial or mammalian expression systems, preserving post-translational modifications for functional studies. It serves as a tool to investigate V-ATPase assembly, pH-dependent signaling, and therapeutic targeting. Recent studies also explore its involvement in autophagy and drug resistance, highlighting its potential as a biomarker or therapeutic target in precision medicine.
×